FIXX Stock Summary and Trading Ideas (Homology Medicines | NASDAQ:FIXX)

Homology Medicines Inc is a United States-based genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality across a range of genetic disorders.

Homology Medicines trades on the NASDAQ stock market under the symbol FIXX.

As of April 19, 2024, FIXX stock price was flat at $0.93 with million shares trading.

FIXX has a beta of 0.28, meaning it tends to be less sensitive to market movements. FIXX has a correlation of 0.00 to the broad based SPY ETF.

FIXX has a market cap of $3.02 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, FIXX stock traded as high as $160.20 and as low as $.93.

FIXX has underperformed the market in the last year with a return of -95.0%, while the SPY ETF gained +21.2%. In the last 3 month period, FIXX fell short of the market, returning -91.1%, while SPY returned +3.0%. However, in the most recent 2 weeks FIXX has outperformed the stock market by returning 0.0%, while SPY returned -4.5%.

FIXX support price is $.92 and resistance is $.95 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that FIXX stock will trade within this expected range on the day.